Skip to main content
Caplight Logo









Cellipont Bioservices

Cellipont Bioservices

Private
The Woodlands, TexasHealthcare & Life Scienceshttps://cellipont.com/

Last Round

Growth Equity

Oct 7, 2024

Company Overview

Cellipont Bioservices is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for cell and gene therapy products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

CDMOcell therapy manufacturinggene therapy developmentcGMP manufacturingcontract manufacturingprocess developmentbiotech manufacturingclinical manufacturinganalytical developmentallogeneic therapyautologous therapybiopharma outsourcingquality controlQCbiotech supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellipont Bioservices Comparables

Compare Cellipont Bioservices with similar companies based on industry and business-model similarity.

Cellipont Bioservices comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Kincell Bio
93%
Theragent
89%
Andelyn Biosciences
88%

Cellipont Bioservices Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityOct 7, 2024
DebtMar 21, 2023
Buyout/LBOJan 11, 2022

Key People

Founding team and executive leadership

Darren Head

Chief Executive Officer

Executive Team

Brett Reynolds

Chief Financial Officer

Executive Team

Mike O'Mara

Chief Operating Officer

Executive Team

Cellipont Bioservices Investors

Notable investors and investment history

Cellipont Bioservices investors
InvestorRounds
OrbiMedDebt
Great Point PartnersGrowth Equity, Buyout/LBO
HealthQuest CapitalGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 7, 2024

    Led by HealthQuest Capital and Great Point Partners.

  • Mar 21, 2023

    Debt round led by OrbiMed

Cellipont Bioservices Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellipont Bioservices Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellipont Bioservices's valuation, stock price, and market status.

Firmographic Details

HeadquartersThe Woodlands, Texas
Employee Range112
Year Founded2002
Last FundingOct 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?